FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000 - Johnson & Johnson (NYSE:JNJ), Mind Medicine (NASDAQ:MNMD)

FDA and Reagan-Udall Foundation are hosting a virtual public meeting on psychedelic research titled Advancing Psychedelic Clinical Study Design, which aims to explore empirical approaches to address issues in drug development.

Related Keywords

Michael Bogenschutz ,Tiffanyr Farchione ,Michael Davis ,Patrizia Cavazzoni ,Carla Canuso ,Robert Barrow ,Johnson Jnjdr ,Johns Hopkins University ,Veterans Administration ,Federation Of State Medical Boards ,Neuroscience Office ,Udall Foundation ,Drug Administration ,Ilan University ,Usona Institute Dr ,Heat Index In Research ,Harvard University ,Technology Inc ,University Of Utah ,Psychiatry Division ,University Of California San Francisco ,Reagan Udall Foundation ,Psychedelic Clinical Study Design ,State Regulated Psychedelics ,Collision Course With ,Says Harvard Law ,Where All ,Drug Evaluation ,Investigational New Drug ,Psychedelic Alpha ,Mind Technology ,Usona Institute ,California San Francisco ,Bar Ilan University ,State Medical Boards ,